Leber hereditary optic neuropathy gene therapy.

IF 3 2区医学 Q1 OPHTHALMOLOGY Current Opinion in Ophthalmology Pub Date : 2023-12-21 DOI:10.1097/icu.0000000000001028

Byron L Lam

引用次数: 0

Abstract

To discuss relevant clinical outcomes, challenges, and future opportunities of gene therapy in Leber hereditary optic neuropathy (LHON).

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Leber 遗传性视神经病变基因疗法。

讨论基因疗法治疗 Leber 遗传性视神经病变 (LHON) 的相关临床结果、挑战和未来机遇。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Current Opinion in Ophthalmology 医学-眼科学

CiteScore

6.80

自引率

5.40%

发文量

120

审稿时长

6-12 weeks

期刊介绍： Current Opinion in Ophthalmology is an indispensable resource featuring key up-to-date and important advances in the field from around the world. With renowned guest editors for each section, every bimonthly issue of Current Opinion in Ophthalmology delivers a fresh insight into topics such as glaucoma, refractive surgery and corneal and external disorders. With ten sections in total, the journal provides a convenient and thorough review of the field and will be of interest to researchers, clinicians and other healthcare professionals alike.